Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Some common medications can harm male fertility, but many effects can be reversed.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

New compounds with carborane showed anti-androgen effects similar to flutamide.

To treat tinea capitis in children, oral antifungal medication is necessary, with newer drugs offering shorter treatment times than the traditional griseofulvin.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

New psoriasis treatments are effective but come with side effects and risks.

Mild essential fatty acid deficiency can cause health issues and is worsened by low-fat diets.

Grouping certain skin cells together activates a growth pathway that helps create new hair follicles.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.